Dr. Divyaswathi Citla Sridhar is a pediatric hematologist whose current research focuses on children's bleeding and clotting disorders. She has a specific interest in bone health in patients
with bleeding disorders and heavy menstrual bleeding in adolescents with bleeding disorders. She received the Hemostasis Thrombosis Research Society DREAM Award grant in 2019 to study practice patterns in diagnosing and treating platelet function disorders.

Dr. Citla Sridhar continues her work on platelet function disorders at ACH. She received the Marion B. Lyon New Scientist Development Award in 2021 to investigate the mechanisms of bone loss associated with hemophilia, hemophilia carriers, and von Willebrand disease. Dr. Citla Sridhar is also involved in several clinical trials in hemophilia, von Willebrand disease, idiopathic thrombocytopenia purpura, and thrombosis.

Medical Degree

  • PSG Institute of Medical Sciences & Research - 2013

Residency

  • University of Texas Health Sciences Center - 2017

Fellowship

  • Case Western Reserve University/University Hospitals of Cleveland - 2020

Related Services

Related Blogs